P
Paolo Sciattella
Researcher at University of Rome Tor Vergata
Publications - 51
Citations - 484
Paolo Sciattella is an academic researcher from University of Rome Tor Vergata. The author has contributed to research in topics: Indirect costs & Medicine. The author has an hindex of 9, co-authored 42 publications receiving 298 citations. Previous affiliations of Paolo Sciattella include Sapienza University of Rome.
Papers
More filters
Journal ArticleDOI
The sexist behaviour of immune checkpoint inhibitors in cancer therapy
Andrea Botticelli,Concetta Elisa Onesti,Ilaria Grazia Zizzari,Bruna Cerbelli,Paolo Sciattella,Mario Occhipinti,Michela Roberto,Francesca Di Pietro,Adriana Bonifacino,Michele Ghidini,Patrizia Vici,Laura Pizzuti,Chiara Napoletano,Lidia Strigari,Giulia d'Amati,Federica Mazzuca,Marianna Nuti,Paolo Marchetti +17 more
TL;DR: Different mechanisms could be involved in sex differences with regard to immunotherapy and these differences could be relevant to identify immunological targets in order to draw studies exploring novel combinations of immunotherapy agents.
Journal ArticleDOI
Cost of poor adherence to anti-hypertensive therapy in five European countries
FS Mennini,FS Mennini,Andrea Marcellusi,Andrea Marcellusi,J.-M. Graf von der Schulenburg,Alastair Gray,Pierre Levy,Paolo Sciattella,M. Soro,Gianandrea Staffiero,Jan Zeidler,Aldo P. Maggioni,Roland E. Schmieder +12 more
TL;DR: In this article, a probabilistic prevalence-based decision tree model was developed to estimate the direct costs of cardiovascular disease related to hypertension in five European countries (Italy, Germany, France, Spain and England).
Journal ArticleDOI
PD-L1 Expression in TNBC: A Predictive Biomarker of Response to Neoadjuvant Chemotherapy?
Bruna Cerbelli,Angelina Pernazza,Andrea Botticelli,Lucio Fortunato,Massimo Monti,Paolo Sciattella,Domenico Campagna,Federica Mazzuca,Maria Mauri,Giuseppe Naso,Paolo Marchetti,Giulia d'Amati,Leopoldo Costarelli +12 more
TL;DR: Data confirm the role of the immune system in the neoplastic progression and in the response to therapy in TNBC and suggest that the expression of this biomarker could be associated with a subpopulation of TNBC more likely to respond to chemotherapy.
Journal ArticleDOI
Cost of chronic and episodic migraine patients in continuous treatment for two years in a tertiary level headache Centre.
Andrea Negro,Paolo Sciattella,Paolo Sciattella,Daniele Rossi,Martina Guglielmetti,Paolo Martelletti,Francesco Saverio Mennini,Francesco Saverio Mennini +7 more
TL;DR: The results provide a valuable estimate of the annual direct cost of CM and EM patients in the specific setting of a tertiary headache centre and confirm the high economic impact of migraine on both the NHS and patients.
Journal ArticleDOI
Economic Aspects in the Management of Diabetes in Italy
Andrea Marcellusi,Andrea Marcellusi,Raffaella Viti,Paolo Sciattella,Gianluca Aimaretti,S. De Cosmo,V. Provenzano,G. Tonolo,Francesco Saverio Mennini,Francesco Saverio Mennini +9 more
TL;DR: This model is the first study that considers real world data and COI model to estimate the economic burden of DM and its comorbidities from the Italian NHS perspective and demonstrates that the implementation of good clinical practice could save over €700 million per year.